DURHAM, NC - May 9, 2019 -
Rho CEO Laura Helms-Reece Named CEO of the Year by

Triangle Business Journal

Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that Laura Helms Reece, DrPH and co-CEO of the company, was named a CEO of the Year by the Triangle Business Journal.

“It is an honor to be included in such a prestigious list of leaders in the Triangle region,” said Helms Reece. "This award is recognition of the impressive job our entire team does leading Rho, including my co-CEO Russ Helms. All of Rho is committed to providing excellent customer service, supporting and retaining our awesome people, and improving our community. We are delighted to be recognized for that."

This is the fifth year of these awards and, as in past years, the list reads like a “Who’s Who” of top local executives. This year’s roundup features 20 executives in top posts from a variety of industries, including manufacturing, technology, banking, real estate, biopharma and sports business. The winners received the honor based solely on responses from their peers: other CEOs or top executives in the Triangle. More than 100 survey recipients voted for the top 20 leaders from a ballot of 48 names. After the internal assessment, what resulted is the standout class of CEOs who help drive the Triangle’s success and make it such a prominent place to work and live.

On April 25, Helms-Reece was recognized at the CEO of the Year dinner gala celebration at The Umstead Hotel & Spa in Cary, North Carolina, along with other 2019 winners.  

To learn more about Rho, please visit www.rhoworld.com.

About Rho

Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For more than 35 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. Please follow us on Facebook, LinkedIn and Twitter.